Drug Shortage Report for SANDOZ AZITHROMYCIN
Report ID | 194749 |
Drug Identification Number | 02332388 |
Brand name | SANDOZ AZITHROMYCIN |
Common or Proper name | AZITHROMYCIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | AZITHROMYCIN |
Strength(s) | 100MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 15ML POS |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-06-12 |
Estimated end date | 2023-07-21 |
Actual end date | 2023-07-10 |
Shortage status | Resolved |
Updated date | 2023-07-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-07-11 | English | Compare |
v5 | 2023-07-10 | French | Compare |
v4 | 2023-07-10 | English | Compare |
v3 | 2023-06-13 | English | Compare |
v2 | 2023-06-12 | French | Compare |
v1 | 2023-06-12 | English | Compare |
Showing 1 to 6 of 6